Small-cap investing used to come with a caveat. Smaller companies were cheaper, scrappier, and more leveraged. They came with higher risks, but potentially higher rewards for investors who went down the rabbit hole and put in the work.

For those who hunted a discounted ETF deal, investing in smaller caps typically meant buying the Russell 2000 when sentiment was poor, waiting for the cycle to turn and letting mean reversion do the rest.

However, in 2026 small caps are no longer the bargain bin of U.S. equities. In fact, by some measures they're the priciest corner of the market. An increasing number of investors are paying a premium for a collection of companies with weaker margins, heavier debt loads and a surprisingly large population that doesn't make money at all.

The Most Expensive Earnings

The numbers are hard to square. Isabelnet's post on X noted how Goldman Sachs' data puts Russell 2000 at 26 times forward earnings, compared with about 24 times for the Nasdaq 100 and 20 times for the S&P 500.

Investors are paying a higher multiple for small caps than for the mega-cap technology complex that dominates the Nasdaq. That discrepancy would be easier to justify if the Russell 2000 were packed with durable compounders, but analysis shows the opposite.

Torsten Slok, Apollo's Chief Economist, warned that 40% of the index's companies were loss-making as early as 2023. Yet, more recently, Slok warned that the unprofitable small caps led the rally off the April 2025 lows. Those stocks rose more than 60%, far outpacing the 38% gain for profitable peers.

In Search of Quality

While forward earnings valuations have limitations, net profit margins show a different – perhaps even more worrying angle. Small-cap net profit margins sit near 4.4%, while large-cap margins are closer to 14.5% to 14.8%.

Balance sheets tell the same story. Small companies carry net debt of roughly 4.5 times EBITDA, versus about 1.5 times for large caps. Investors are paying a premium multiple for lower profitability, weaker balance sheets, and greater rate sensitivity at a time when the Fed is flirting with an interest rate hike.

The trap is partly structural. The Russell 2000 is market-cap weighted and lacks the strict quality filters that would keep weaker companies out. That means major ETFs tracking it, including the iShares Russell 2000 ETF (IWM), are forced to carry the good, the bad and the "zombie" companies that survive more on market access than operating strength.

Investors appear to be noticing. In 2026, IWM has suffered more than $8 billion in net outflows, while the iShares Core S&P Small-Cap ETF (IJR) has attracted capital. For comparison, the IJR applies an earnings-quality screen. It doesn't automatically admit every small company just because it's small.

IWM vs IJR year-to-date; Source: TradingView

That distinction matters. Small-cap exposure isn't the problem, but blind small-cap exposure might be. Betting on a recovery in smaller companies starts with work – screening for profitability, leverage and real earnings power.

Otherwise, buying the broad Russell 2000 today means paying the market's highest price for its lowest-quality merchandise. That bet isn't a value trade. It's a valuation trap wearing a small-cap label.